RetroSense Therapeutics
acquired by AllerganAnn Arbor, US · Founded 2014 · 1 known investors
First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
Biotech
Founders & leadership
TC
Terry CrossDirector
CG
Cam GallagherDirector
SA
Sean AinsworthExecutive Officer, Director
GL
George LasezkayDirector
KK
Kenneth KouskyDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.6MraisedOct 2015 · 22 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.